AAA May 2016

Corporates help TransMedics with $51m funding transplant

TransMedics, a US-based medical device producer focused on making the transport of organ transplants safer, has closed a $51.2m funding round co-led by pharmaceutical firm Pharmstandard International. Pharmstandard, which participated through its InBio Ventures unit, co-led the round alongside Fayerweather Fund, Ervington Investments and BioStar Ventures. Biotechnology company Lung Biotechnology PBC, Abrams Capital, Flagship Ventures… Continue reading Corporates help TransMedics with $51m funding transplant